Lack of association between the MDM2 promoter polymorphism SNP309 and clinical outcome in chronic lymphocytic leukemia.
Kaderi MA, Mansouri M, Zainuddin N, Cahill N, Gunnarsson R, Jansson M, Kimby E, Aleskog A, Lundin J, Glimelius B, Melbye M, Juliusson G, Jurlander J, Rosenquist R.
Kaderi MA, et al. Among authors: rosenquist r.
Leuk Res. 2010 Mar;34(3):335-9. doi: 10.1016/j.leukres.2009.06.006. Epub 2009 Jul 1.
Leuk Res. 2010.
PMID: 19573916